,2026/2027
NAPLEX Pharmacy Practice
Questions 2026/2027 Definitive Exam
Preparation: Complete Study Guide,
Targeted Practice Questions, and
Final Test Bank Review
Question 16
Question 1
A medication has a systemic clearance of 5 L/hour and a volume of distribution of 50
L. What is its elimination rate constant?
A. 0.01 hour⁻¹
B. 0.10 hour⁻¹
C. 10 hours
D. 250 hour⁻¹
Correct Answer: B. 0.10 hour⁻¹
Rationale: The elimination rate constant is calculated using ke=Cl/Vd. Dividing 5
L/hour by 50 L gives 0.10 hour⁻¹. The units are reciprocal time, not hours. The other
values do not represent valid results from the clearance-to-volume relationship.
Question 2
A 38-year-old patient arrives in the emergency department with continuous
generalized tonic-clonic seizure activity lasting more than 5 minutes. Intravenous
access has been established. Which medication should be administered first to
terminate the seizure rapidly?
A. Intravenous phenytoin
B. Intravenous lorazepam
C. Intravenous levetiracetam
D. Intravenous valproate
Correct Answer: B. Intravenous lorazepam
Rationale: Intravenous lorazepam is a first-line benzodiazepine for rapidly
terminating status epilepticus when intravenous access is available. Phenytoin,
levetiracetam, and valproate are generally used as second-line antiseizure medications
,2026/2027
after initial benzodiazepine therapy. Delaying benzodiazepine treatment may increase
the risk of neuronal injury, respiratory complications, and treatment-resistant seizures.
Question 3
A total parenteral nutrition formulation contains 250 g of dextrose. Approximately
how many kilocalories are supplied by the dextrose component?
A. 750 kcal
B. 850 kcal
C. 1,000 kcal
D. 1,100 kcal
Correct Answer: B. 850 kcal
Rationale: Intravenous dextrose provides approximately 3.4 kcal per gram.
Therefore:
250 g × 3.4 kcal/g = 850 kcal
The value of 4 kcal/g applies to enteral or dietary carbohydrates rather than
intravenous dextrose.
Question 4
A patient taking an oral medication metabolized extensively by hepatic CYP enzymes
begins treatment for tuberculosis. Several weeks later, the medication’s effectiveness
decreases significantly. Which tuberculosis medication is the most likely cause?
A. Rifampin
B. Fluconazole
C. Verapamil
D. Amiodarone
Correct Answer: A. Rifampin
Rationale: Rifampin is a potent inducer of several hepatic CYP enzymes and
transport proteins. Enzyme induction accelerates the metabolism of many
medications, potentially reducing their concentrations and effectiveness. Fluconazole,
verapamil, and amiodarone are generally associated with enzyme inhibition rather
than induction.
Question 5
, 2026/2027
A patient receives 500 mL of a 10% intravenous lipid emulsion as part of parenteral
nutrition. Approximately how many kilocalories does the lipid emulsion provide?
A. 500 kcal
B. 550 kcal
C. 1,000 kcal
D. 1,500 kcal
Correct Answer: B. 550 kcal
Rationale: A 10% intravenous lipid emulsion provides approximately 1.1 kcal/mL.
500 mL × 1.1 kcal/mL = 550 kcal
A 20% emulsion provides approximately 2 kcal/mL, whereas a 30% emulsion
provides approximately 3 kcal/mL.
Question 6
A patient with a documented severe egg and soybean allergy requires rapid
intravenous blood-pressure control. Which medication should raise the greatest
concern because its formulation contains egg-yolk phospholipids and soybean oil?
A. Clevidipine
B. Labetalol
C. Nicardipine
D. Enalaprilat
Correct Answer: A. Clevidipine
Rationale: Clevidipine is formulated as a lipid emulsion containing soybean oil and
egg-yolk phospholipids and is contraindicated in patients with allergies to these
components. Labetalol, nicardipine, and enalaprilat do not use the same lipid-
emulsion vehicle.
Question 7
A medication has an elimination rate constant of 0.10 hour⁻¹. What is its approximate
elimination half-life?
A. 0.069 hour
B. 0.693 hour
C. 6.93 hours
D. 10 hours